1. insights
  2. strategy catalyst
  3. health policy and advocacy
  4. eli lillys glp 1 shortages are resolved
Strategist | strategy-catalyst

Eli Lilly’s GLP-1 shortages are resolved

Visual banner featuring the text "The Strategist" on the left side with a light geometric pattern background. On the right side, a blue silhouette of a human head contains two interlocking gears, symbolizing strategic thinking and problem-solving. The background transitions from light to dark blue.
Related Topics:
Health Policy and Advocacy
Relevant Roles:
Chief Strategy Officers

  • On Oct. 2, the FDA announced that Eli Lilly’s GLP-1 drug tirzepatide (sold as Mounjaro for diabetes treatment and Zepbound for weight loss) is no longer facing a shortage.

If your organization is a member, you already have access.

Log in using your organizational email

Interested in membership?

Contact us to start your journey today